1. Seppä K, Heinilä K, Sillanaukee P, Saarni M. Evaluation of macrocytosis by general practitioners. J Stud Alcohol 1996; 57(1):97–100. doi:10.15288/jsa.1996.57.97
2. Aslinia F, Mazza JJ, Yale SH. Megaloblastic anemia and other causes of macrocytosis. Clin Med Res 2006; 4(3):236–241. pmid:16988104
3. Steensma DP. Dysplasia has a differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors. Curr Hematol Malig Rep 2012; 7(4):310–320. doi:10.1007/s11899-012-0140-3
4. Stabler SP. Clinical practice. Vitamin B12 defi ciency. N Engl J Med 2013; 368(2):149–160. doi:10.1056/NEJMcp1113996
5. Green R, Datta Mitra A. Megaloblastic anemias: nutritional and other causes. Med Clin North Am 2017; 101(2):297–317. doi:10.1016/j.mcna.2016.09.013
6. Sobczynska-Malefora A, Harrington DJ. Laboratory assessment of folate (vitamin B9) status. J Clin Pathol 2018; 71(11):949–956. doi:10.1136/jclinpath-2018-205048
7. Green R. Vitamin B12 defi ciency from the perspective of a practicing hematologist. Blood 2017; 129(19):2603–2611. doi:10.1182/blood-2016-10-569186
8. Institute of Medicine (US) Standing Committee on the Scientifi c Evaluation of Dietary Reference Intakes and its Panel on Folate, other B Vitamins, and Choline. Dietary Reference intakes for Thiamin, Ribofl avin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academies Press (US); 1998.
9. Schjonsby H. Vitamin B12 absorption and malabsorption. Gut 1989; 30(12):1686–1691. doi:10.1136/gut.30.12.1686
10. Bizzaro N, Antico A. Diagnosis and classifi cation of pernicious anemia. Autoimmun Rev 2014; 13(4–5):565–568. doi:10.1016/j.autrev.2014.01.042
11. Coati I, Fassan M, Farinati F, Graham DY, Genta RM, Rugge M. Autoimmune gastritis: pathologist’s viewpoint. World J Gastroenterol 2015; 21(42):12179–12189. doi:10.3748/wjg.v21.i42.12179
12. Cavalcoli F, Zilli A, Conte D, Massironi S. Micronutrient defi ciencias in patients with chronic atrophic autoimmune gastritis: a review. World J Gastroenterol 2017; 23(4):563–572. doi:10.3748/wjg.v23.i4.563
13. Hesdorffer CS, Longo DL. Drug-induced megaloblastic anemia. N
Engl J Med 2015; 373(17):1649–1658. doi:10.1056/NEJMra1508861
14. Briani C, Dalla Torre C, Citton V, et al. Cobalamin defi ciency: clinical picture and radiological fi ndings. Nutrients 2013; 5(11):4521–4539. doi:10.3390/nu5114521
15. Lachner C, Steinle NI, Regenold WT. The neuropsychiatry of vitamin B12 defi ciency in elderly patients. J Neuropsychiatry Clin Neurosci 2012; 24(1):5–15. doi:10.1176/appi.neuropsych.11020052
16. Wang YH, Yan F, Zhang WB, et al. An investigation of vitamin B12 defi ciency in elderly inpatients in neurology department. Neurosci Bull 2009; 25(4):209–215. doi:10.1007/s12264-009-0224-9
17. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin defi ciency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318(26):1720–1728. doi:10.1056/NEJM198806303182604
18. Hector M, Burton JR. What are the psychiatric manifestations of vitamin B12 defi ciency? J Am Geriatr Soc 1988; 36(12):1105–1112. doi:10.1111/j.1532-5415.1988.tb04397.x
19. Remacha AF, Souto JC, Pinana JL, et al. Vitamin B12 defi ciency, hyperhomocysteinemia and thrombosis: a case and control study. Int J Hematol 2011; 93(4):458–464. doi:10.1007/s12185-011-0825-8
20. Gnanaraj J, Parnes A, Francis CW, Go RS, Takemoto CM, Hashmi SK. Approach to pancytopenia: diagnostic algorithm for clinical hematologists. Blood Rev 2018; 32(5):361–367. doi:10.1016/j.blre.2018.03.001
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.